Name (Synonyms) | Correlation | |
---|---|---|
drug23 | 1: discontinuation of RAS blocker therapy Wiki | 1.00 |
drug34 | 2: continuation of RAS blocker therapy Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D002318 | Cardiovascular Diseases NIH | 0.19 |
D007239 | Infection NIH | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001626 | Abnormality of the cardiovascular system HPO | 0.19 |
There is one clinical trial.
This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies.
Description: To evaluate the prevalence of COVID-19 exposure to healthcare staff, community 1st responders and patients. and patient population within a subspecialty
Measure: prevalence of COVID-19 exposure Time: Mar-Dec 2020Description: correlation between the test results with the presence or lack of COVID-19 symptoms or illness
Measure: correlation between the test results with the presence or lack of COVID-19 symptoms or illness Time: Mar-Dec 2020Description: correlate pre-existing risk factors with test results and baseline symptoms
Measure: correlate pre-existing risk factors with test results and baseline symptoms Time: Mar-Dec 2020Description: correlate subsequent healthcare utilization with test results and baseline symptoms
Measure: correlate subsequent healthcare utilization with test results and baseline symptoms Time: Mar-Dec 2020